BPS Bioscience Inc.

Heading to the Life Science Exhibits Research Supplier Product Show at Columbia University today? Be sure to stop by our booth from 11am- 1pm and chat with our Sr. Territory Sales Manager, Megan Conlon! She'll be there to discuss how our products can support your research needs. #drugdiscovery #research #researchsupplierproductshow

Luciferase-based reporter cell lines are invaluable for detecting cellular responses to extracellular signals in vitro, enabling high-throughput screening and profiling of inhibitors or activators. In this webinar, Junguk Park and Vanda Lopes discuss reporter cell line development and optimization in three functional categories: cytokine signaling (TSLP and IL-23), GPCR signaling (GLP-1 and MUC1), and enzyme activity (ADAR1). Watch now: https://hubs.ly/Q02TybVh0 #webinar #celllines #drugdiscovery

With flu season right around the corner, we are seeing groundbreaking advancements in vaccine and therapeutic options. One of the latest innovations involving engineered T cells with a unique T Cell Receptor (TCR) are designed to recognize influenza antigens. Express our influenza HA-specific TCR lentivirus in one of our TCR-knockout NFAT reporter cells to design a functional assay co-culturing T cells with antigen-presenting cells: https://hubs.ly/Q02SSn7Y0 #drugdiscovery #TCR #flu

Check out how our PDE (phosphodiesterase) enzymes were used to discover PDE11A4 Inhibitors for Age-Related Cognitive Decline: https://hubs.ly/Q02SSj6z0 https://hubs.ly/Q02SSbkV0 "In vitro enzyme assays were conducted via the Ba(OH)2 precipitation method of Wang et al. using BPS Bioscience's recombinant human PDE3A, PDE4D3, PDE5A, PDE6C, PDE10A1, and PDE11A4." #phosphodiesterase #aging #neuroscience

Therapeutic options for autoimmune and inflammatory diseases are steadily improving, with researchers developing targeted treatments to restore immune balance. BPS Bioscience provides essential tools to help scientists advance projects and develop innovative therapeutic strategies. Quantify the effect of your candidate drug on TL1A, TLSP, OX40 signaling pathways, and more: https://hubs.ly/Q02SGJfX0

Exciting developments in the fields of aging and neuroscience: Anne Brunet's research team just published an article shedding light on the role of glucose metabolism in the aging of neural stem cells. Such findings could lead to innovative approaches to combat age-related cognitive decline and enhance brain health. A must-read for those interested in the intersection of metabolism, aging, and neuroscience. #aging #stemcells# neuroscience https://lnkd.in/gkmRh-Pv

We've had a fantastic time meeting everyone at the Discovery on Target conference in Boston this week! If you haven't stopped by yet, make sure to swing by our booth and learn more about how our products can support your research. We'd love to connect! #drugdiscovery #discoveryontarget #DOT #DOT2024

Heading to the Research Supplier Product Show at John's Hopkins University today? Be sure to stop by our booth from 11am- 1pm and chat with our Sr. Territory Sales Manager, Lisa MacKenzie! She'll be there to discuss how our products can support your research needs. #drugdiscovery #research #researchsupplierproductshow

BCMA (B Cell Maturation Antigen), is a cell surface receptor mainly expressed in mature B lymphocytes and a clinically validated oncology target. Therapeutic strategies include CAR T cells, monoclonal antibodies, antibody drug conjugates, and Bi-specific immune engagers. Discover our BCMA Cell products: https://hubs.ly/Q02R8lfC0 #drugdiscovery #BCMA

Register today to attend the "Reporter Cell Line Development and Optimization for High Throughput Screening" webinar on September 24th at 2:30 PM ET! Our Director of Cell Based Assay Development, Junguk Park and Product Manager, Vanda Lopes will discuss BPS luciferase reporter cell lines. We hope to see you there! #celllines #webinar #drugdiscovery https://hubs.ly/Q02QClLV0